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Edited by Horst FeldmannAbstract The target of rapamycin (TOR) is an ancient eﬀector
of cell growth that integrates signals from growth factors and
nutrients. Two downstream eﬀectors of mammalian TOR, the
translational components S6K1 and 4EBP1, are commonly used
as reporters of mTOR activity. The conical signaling cascade ini-
tiated by growth factors is mediated by PI3K, PKB, TSC1/2 and
Rheb. However, the process through which nutrients, i.e., amino
acids, activate mTOR remains largely unknown. Evidence exists
for both an intracellular and/or a membrane bound sensor for
amino acid mediated mTOR activation. Research in eukaryotic
models, has implicated amino acid transporters as nutrient sen-
sors. This review describes recent advances in nutrient signaling
that impinge on mTOR and its targets including hVps34, class
III PI3K, a transducer of nutrient availability to mTOR.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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The coordinated control of cell growth to produce a geneti-
cally predetermined cell size, organ shape and body plan is lar-
gely directed by the mammalian target of rapamycin (mTOR).
A large protein of 280 kDa, mTOR consists of a number of
Huntington, EF3, A subunit of PP2A, and TOR1 repeats
(HEATrepeats), common inprotein–protein interaction; a large
Frap, ATM, and TRAP PIKK-like domain (FAT domain); a
FKBP12-rapamycin binding domain (FRBDomain) a C-termi-
nal kinase domain; and two regulatory domains, termed the
negative regulatory domain (NRD Domain) and FAT domain
C-terminal (FAT/C Domain) (reviewed in [1]). The kinase do-
main is similar to the phosphatidylinositol 3OH-kinase (PI3K)
domain and in mammals mTOR was originally considered a
phosphotidylinositol-4 kinase [2]. Further research, however,
showed that TOR was in fact a protein kinase, belonging to
the PI3K-related family of protein kinases, which also includes
ATM, ATR and DNA-dependent protein kinase [3].
Stimulation of PI3K by growth factors such as insulin re-
sults in the initiation of a number of signaling cascades thatAbbreviations: HEAT domains, Huntington, EF3, A subunit of PP2A,
and TOR1 Domains; FAT, Frap, ATM, and TRAP PIKK like do-
mains; FAT/C, FAT domain C-terminal; FRB, FKBP12-Rapamycin
Binding domain; NRD, Negative Regulatory Domain
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doi:10.1016/j.febslet.2006.04.068lead to growth and proliferation, a cellular phenomenon con-
served throughout metazoans (Fig. 1). In mammals, receptor
interaction with insulin results in recruitment of insulin recep-
tor substrates (IRS) to the cell membrane [4]. Subsequently,
recruitment and stimulation of the class I PI3K produces the
phosphatidylinositol second messenger PIP3 [5]. PIP3 binds
to the pleckstrin homology (PH) domain of several proteins,
in particular to the Protein A, G and C (AGC) serine/threo-
nine kinase PKB/AKT, a pro-growth, pro-survival kinase [6].
Binding of PIP3 to its PH domain recruits PKB to the cell
membrane where it is activated through phosphorylation by
PDK1 and PDK2 [7,8]. Activated PKB phosphorylates the
TSC1/2 complex resulting in their dissociation and degrada-
tion, thereby releasing the small GTPase Rheb from the inhib-
itory GAP activity of TSC2 [9–13]. Recent studies illustrate a
direct interaction between Rheb and mTOR, which stimulates
its kinase activity [14].
Two alleles, TOR1p and TOR2p, were originally described
in a screen of yeast mutants resistant to toxic doses of the
anti-fungal, bacterial macrolide, rapamycin [15]. In mammals,
rapamycin blocks mTOR function by forming an inhibitory
complex with the immunophilin FKBP12, which binds to
and attenuates the ability of mTOR to phosphorylate down-
stream substrates [16,17], including S6K1 [3,18–20] as well as
the 4E binding protein, 4E-BP1 [21–23], a repressor of transla-
tion initiation factor 4E [24]. In this rapamycin sensitive path-
way mTOR is bound to two additional proteins, raptor and
mLst8/GbL, to make Complex 1. Raptor and mLst8 are
homologues of the yeast KOG1p and Lst8p, respectively
[25–27]. mTOR interacts with downstream substrates through
raptor, which recognizes mTOR substrates through their TOR
signaling (TOS) motifs [28], whereas mLST8 is required to
make a competent signaling complex that can respond to
nutrient and energy inputs [27]. Recent studies show that
mTOR also exists in a second signaling complex with mLST8
and a protein termed rictor, rather than raptor. Moreover, this
second complex is proposed to directly control PKB phosphor-
ylation and activation and, unlike Complex 1, Complex 2 is
rapamycin resistant [8,29].
Activation of mTOR through both growth factor and nutri-
ent sensitive pathways results in the upregulation of protein syn-
thesis. Phosphorylation of 4E-BP1 by mTOR induces its
dissociation from initiation factor eIF4E [23]. Relieved of 4E-
BP1, eIF4E is free to interact with the eIF-4G subunit of the
eIF-4F complex [30]. Once these associations are complete,
the secondary structure of mRNA can be melted allowing the
40S ribosomal subunit to scan the mRNA until it encounters
the ﬁrst AUG initiation codon and promotes translation. Inblished by Elsevier B.V. All rights reserved.
Fig. 1. Insulin and amino acid signals converge on mTOR through independent PI3K signals. Insulin binds to its receptor resulting in activation of
the class I PI3K which recruits PKB to the cell membrane. Upon activation by PDK1 and PDK2 PKB inhibits TSC1/2 which releases Rheb from its
intrinsic GTPase activity. Rheb-GTP bound to mTOR activates mTOR kinase activity resulting in phosphorylation of its downstream targets S6K1
and 4EBP1. Meanwhile amino acid availability positively regulates the activity of the class III PI3K hVPS34. hVPS34 produces the second messenger
PI(3)P which activates mTOR through unknown mechanisms.
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somal protein S6, whose phosphorylation was earlier shown to
be implicated in increased rates of protein synthesis [31]. The re-
cent identiﬁcation of four additional substrates is also consis-
tent with a role in cell growth, including translation initiation
factor 4B, which facilitates the unwinding of the 5 0 ends of
mRNA [32], eEF2 kinase, which mediates the phosphorylation
of translation elongation factor 2, involved in controlling ribo-
somal transit rates [33], BAD, a pro-apoptotic protein [34] and
most recently SKAR a nuclear protein proposed to couple tran-
scription with pre-mRNA splicing and mRNA export [35]. The
role of these targets in cell growth is consistent with the eﬀect of
the S6Ks on growth, as established in deletion studies in both
Drosophila [98] and in the mouse [36,37].
The ability of nutrients to modulate mTOR signaling down-
stream to its substrates is relatively well documented, however
little is known with regard to the identity of the upstream eﬀec-
tors of this branch of the signaling pathway. Evidence exists
for both an intracellular and/or a membrane bound extracellu-
lar sensor for amino acid stimulation of the mTOR pathway.
Research in yeast, Drosophila, and mammalian settings have
implicated amino acid transporters as sensors of nutrient avail-
ability. Investigations in Drosophila and yeast have described
amino acid transporters as genetically epistatic to TOR activity
while, in a mammalian setting, mTOR activity is linked to ami-
no acid transporter transcription, translation and turnover.
Considering the well conserved nature of the TOR pathway
in eukaryotes, it seems likely that membrane nutrient trans-
porters are able to promote traditional signaling cascades be-
yond their well known function of regulating nutrient
concentration within the cell. The importance of the nutrient
branch of the mTOR signaling pathway is underscored by re-cent studies showing that nutrient overload, while driving cell
growth, also acts to suppress insulin signaling, leading to
hyperglycemia and insulin resistance [36,38]. Moreover, obes-
ity and type 2 diabetes have recently been implicated as risk
factors in a number of cancers [39,40], consistent with the clin-
ical importance of rapamycin, and its derivatives in the treat-
ment of solid tumors [1,41]. This review will describe recent
advances in a variety of eukaryotic models of nutrient signal-
ing that impinge on the mTOR kinase and its targets including
the recent identiﬁcation of hVps34, class III PI3K, as a trans-
ducer of nutrient availability to mTOR [42,43].2. Yeast studies
Many advances in the ﬁeld of cell growth control in the
mammalian setting were initially described in yeast. The
TOR1 and TOR2 alleles as well as the distinct TOR complexes
are examples of the advantages that a simple eukaryotic system
confers in describing novel pathways and potential interac-
tions. In yeast, Torp and Lst8p have been implicated in the
nutrient responsive, mitochondria-to-nucleus, retrograde sig-
naling (Fig. 2). The most detailed reports on this pathway in-
volve the de-repression of Rtg1p and Rtg3p target genes, many
of which control the supply of intermediates necessary for the
tricarboxylic acid cycle (reviewed in [44]). In brief, restriction
of a suitable glutamate source results in Rtg1p:Rtg3p tran-
scription complex being released from a repressed state leading
to the subsequent upregulation of target gene families, includ-
ing CIT1, CIT2, ACO1, IDH1 and IDH2 [45]. Glutamate or
glutamine is sensed in yeast by the membrane bound SPS sen-
sor which negatively regulates Rtg2p. Rtg2p is also a sensor of
Fig. 2. The Rtg1p:Rtg3p mitochondrial retrograde response in yeast is
directed by the SPS amino acid sensor, Torp, and Lst8p. The
Rtg2p:Mks1p complex integrates signals from the SPS sensor, mito-
chondrial dysfunction and Torp to regulate the activity of the
Rtg1p:Rtg3p transcription factors. Lst8p also negatively regulates
Rtg1p:Rtg3p function through a Torp independent mechanism.
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Rtg1p:Rtg3p transcription complex. When glutamine is avail-
able and mitochondrial function is normal the Rtg1p:Rtg3p
transcription complex is sequestered in the cytoplasm and
Rtg3p is phosphorylated at several sites. If the retrograde
pathway is activated Rtg3p becomes partially dephosphoryl-
ated and Rtg1p and Rtg3p relocalize to the nucleus. Deletion
of RTG2 results in both hyperphosphorylation of Rtg3p and
cytoplasmic localization of the Rtg1p:Rtg3p transcription
complex regardless of retrograde signals [46].
Genetic screens in yeast that bypass the requirement for
Rtg2p in the retrograde response resulted in the identiﬁcation
of MKS1 by three independent laboratories [47–49]. Cells deﬁ-
cient in MKS1 have constitutively high CIT2 expression and
are insensitive to extracellular glutamate [50,51]. Partially
dephosphorylated Mks1p and Rtg2p are found in complex to-
gether during the retrograde response, but when retrograde sig-
naling is suppressed Mks1p becomes hyperphosphorylated and
is bound to the 14-3-3 yeast homologues Bmh1p and Bmh2p.
The Torp kinase in Saccharomyces cerevisiae is intimately
linked with the retrograde response both directly and through
Lst8p (Fig. 2). Treatment of yeast cells with rapamycin results
in Rtg1p:Rtg3p complex dependent gene expression [52,53].
This rapamycin sensitive response depends on the activity of
Rtg2p, placing the eﬀect of Torp upstream, perhaps at the
point of the SPS sensor. Crespo et al. [54] have also described
a glutamine sensitive input to the Rtg1p:Rtg3p transcription
complex, which is controlled by Torp. In more recent studies,
Dilova et al. [47,55] have reﬁned the independent glutamine/
glutamate sensing event and Torp signaling events, arguing
they converge on Mks1p, and not the SPS sensor, to regulate
Rtg1p:Rtg3p complex activity. In these studies, glutamine/glu-
tamate sensitivity were completely dominant to Torp signals in
regards to Mks1p phosphorylation state [55].
Lst8p has also been linked to the retrograde response where
it acts as a negative regulator of the pathway. Liu et al. [48]
identiﬁed a series of LST8 mutants that increased CIT2 expres-
sion independent of glutamine availability. Some of these mu-tants were dependent on Rtg2p activity while others bypassed
the Rtg2p requirement to activate the Rtg1p:Rtg3p transcrip-
tion complex. This has led to the ﬁnding that Lst8p likely acts
on the retrograde response at two sites, one upstream of
Rtg2p, i.e., Rtg2p dependent, and one downstream of Rtg2p,
i.e., Rtg2p independent. The Rtg2p-dependent LST8 mutation
was originally described as a point mutation at the C-terminus
that results in a general amino acid permease (Gap1p) sorting
defect [56]. Since sublethal concentrations of rapamycin result
in a Gap1p sorting defect similar to the LST8 mutant pheno-
type [57] it is tempting to speculate that this mutant is a mod-
ulator of the Torp activity that converges on Mks1p described
by Dilova et al. [55]. Recent evidence supports a separation of
glutamine sensing Torp-Lst8p regulation of the Rtg1p:Rtg3p
transcription complex, and a Torp-independent, Lst8p-speciﬁc
regulation of Rtg1p:Rtg3p complex activation through mito-
chondrial dysfunction [58].
The importance of the Torp pathway in nutrient uptake and
regulation of amino acid permeases has also been described for
Schizosaccharomyces pombe leucine auxotrophs [59]. Rapamy-
cin or disruption of TOR1 results in defective leucine transport
and downregulation of three putative amino acid permeases.
Reduction of Tsc1p or Tsc2p, results in constitutive Rhebp
and Torp activity, and causes a reduction in arginine uptake
[60]. Similarly, Rhebp-deﬁcient S. cerevisiae have an increased
arginine uptake phenotype [61], whereas S. pombe deﬁcient for
Rhebp exhibit cell cycle arrest in G1 and a phenotype similar
to that observed for nitrogen starvation [62]. Indeed, one could
imagine a system where the availability of nitrogen and/or ami-
no acids results in expression of their respective transporters
for uptake mediated by the Torp pathway.3. Mammalian cells
Observations of increased protein degradation due to amino
acid deﬁciency and increased protein synthesis due to amino
acid supplementation in cell culture were ﬁrst reported in the
early 1980s [63]. Amino acids as signaling molecules were ﬁrst
described in studies of cultured hepatocytes where amino acids
could inhibit the progression of macroautophagy [64]. The
same researchers determined that this inhibitory eﬀect was
dependent on phosphorylation of the small ribosomal subunit
S6 [65]. Soon after, several laboratories demonstrated the spe-
ciﬁc regulation by phosphorylation of mTOR substrates S6K1
and 4EBP1 due to amino acid stimulation, in particular the
branched chain amino acid leucine. Studies performed in adi-
pocytes [66], Chinese Hamster Ovary (CHO) cells [67,68], hep-
atoma and myotubes [69] myoblasts [70], pancreatic b-cells [71]
and hepatocytes [72] all show sensitivity of phosphorylation
status of mTOR substrates to amino acid concentrations. That
is, amino acid depletion results in a rapid dephosphorylation
of S6K1 and 4EBP1 while addition of amino acids, especially
leucine, can rescue this eﬀect in a rapamycin-sensitive manner.
These studies spurred investigation intended to discover a
mammalian amino acid sensor regulating mTOR activity.
Researchers used several leucine analogues and catabolites to
determine whether leucine itself or a leucine derivative was
responsible for mTOR activation. Shigemitsu et al. [73] indi-
cated leucine chirality (i.e., L-leucine), the four branched car-
bon structure and the primary amine as all necessary to
stimulate S6K1 activity. Lynch et al. [74] described equivalent
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rapamycin treatment, exposure of cells to the leucine derivative
N-acetylleucine amide results in inhibition of S6K1 activation
and G1 cell cycle arrest [75]. Since the cellular eﬀects of rapa-
mycin treatment and amino acid deprivation are paralleled by
Ac-Leu-NH2 treatment, this compound will be a useful tool in
determining the leucine-speciﬁc eﬀects on mTOR signaling.
Fox et al. [76] showed a potent response of 4EBP1 phosphor-
ylation in response to the addition of a-ketoisocaproate (KIC).
KIC is a leucine intermediate metabolite resulting from the
transamination of leucine by the branched chain amino acid
transferase (BCAT). This is a reversible step in leucine metabo-
lism and is coupled to the regulation of the rate-limiting irrevers-
ible activity of the branched chain a-keto acid dehyrdogenase
(BCKDH) complex. KIC stimulation of 4EBP1 was reversed
by addition of (Aminooxy)acetic acid, an inhibitor of BCAT
activity, indicating that the observed stimulationwas due to con-
version of KIC to leucine. Still, due to the pleiotropic eﬀect of
AOAA on all amino acid transferases, the possibility remained
that BCKDH activity induced by KIC was modulating mTOR.
Lynch et al. [77] observed the requirement for much higher con-
centrations of leucine to stimulate BCKDH than was necessary
to stimulate mTOR indicating that BCKDH was involved only
in leucine oxidation and not mTOR signaling.
Earlier studies were able to illustrate a suppression of
macroautophagy and proteolysis with leucine as well as a
non-transportable multiple antigen peptide made of eight N-
terminal leucine residues (MAP-Leu8) [78,79]. Although this
cell-impermeant synthetic peptide clearly suppresses autoph-
agy more recent investigations have shown that stimulation
of S6K1 or 4EBP1 is not responsive to MAP-Leu8 [74,80].
These results indicate that the extracellular receptor that
suppresses cellular autophagy is independent of the leucine
receptor that signals to mTOR.
Considering the high aﬃnity for leucine of the system L ami-
no acid transporters, it is likely they are involved in initiating
the mTOR signal. The system L transporter light chain subunit
LAT1 is upregulated in several cancerous states when com-
pared to normal tissue (reviewed in [81]). Increasing the expres-
sion of this obligatory transporter would give tumors a distinct
growth advantage as they would be able to scavenge essential
amino acids and provide increased signaling to the mTOR
complex. In fact transformed cells in culture display increased
uptake of amino acids compared to their parental lines [82].
The upregulation of LAT1 in tumors and subsequent upregu-
lation of mTOR activity may constitute a positive feedback
loop as transcription of LAT1 is induced by a rapamycin sen-
sitive PDGF stimulation [83]. While sensitive to rapamycin the
induction of LAT1 mRNA by PDGF is resistant to ERK,
MEK, JNK and PI3K inhibitors implicating only mTOR in
the transcriptional regulation of LAT1. The PDGF-induced
increase in expression of LAT1 message is well correlated with
heightened system L activity over the same period. Lynch et al.
[74] and Kanazawa et al. [80] both employed the system L
competitive inhibitor 2-amino-3-norbane carboxylic acid
(BCH) to examine the system L contribution to leucine-in-
duced mTOR signaling. Both research groups found no eﬀect
of BCH on leucine’s ability to stimulate the mTOR dependent
phosphorylation of S6K1 or 4EBP1. In fact, the ratio of hyper-
phosphorylated to unphosphorylated S6K1 appears to be
greater after treatment with BCH and stimulation by leucine
than with leucince stimulation alone [80]. Other groups haveused translation inhibitors such as cycloheximide (CHX) to
block protein synthesis and subsequently allow signaling to
S6K1 by insulin even in the absence of amino acids [84]. These
investigators conclude that inhibition of protein synthesis re-
sults in an increase in the intracellular amino acid concentra-
tions allowing mTOR signaling to progress.
Considering the cellular consequences of MAP-Leu8, BCH
and CHX on S6K1 and 4EBP1 in regard to mTOR signaling
it is postulated that the signal from leucine to mTOR origi-
nates from an intracellular receptor. Iiboshi et al. [85] sug-
gested that the inhibition of S6K1 phosphorylation during
amino acid deprivation was the result of accumulation of un-
charged tRNA. This group observed inhibition of S6K1 phos-
phorylation by amino acid alcohols which competitively
inhibit tRNA synthetases. Other groups, however, have found
no eﬀect of amino acid alcohols on S6K1 or 4EBP1 phosphor-
ylation state [86], and work from our lab indicates that amino
acid deprivation does not induce accumulation of uncharged
tRNA within the period necessary to abolish S6K1 activity
[19]. Leucine-induced phosphorylation of 4EBP1 and S6K1
during BCH-blocked leucine transport argues for the presence
of an amino acid receptor that acts at the membrane to sense
intra and extracellular amino acids perhaps via interaction
with amino acid transporters.
Gao et al. [87] examine the eﬀect of TSC1/2 loss on the ami-
no acid signal to mTOR. They report that the S6K1 is resistant
to inhibition from amino acid deprivation in cells lacking
TSC1/2. Recent data from our lab [42] and others [88] shows
that TSC1/2 is not required to transduce the amino acid signal
to mTOR. While Smith et al. [88] describes the response of
TSC2 null cells to amino acid deprivation and stimulation,
Nobukuni et al. [42] expands on this report with the use of
TSC2 siRNA and TSC2 null cells. We show that S6K1 phos-
phorylation is completely resistant during serum starvation
in either TSC2-reduced background compared to wild-type.
On the other hand, S6K1 is still deactivated during amino acid
deprivation in both TSC2 depletion settings. Similarly, overex-
pression of TSC1/2 or Rheb had no eﬀect on amino acid con-
centrations within the cell during amino acid deprivation or
stimulation, opposing the model proposed by Saucedo et al.
[89]. Since amino acids signal to mTOR in a TSC1/2-deﬁcient
setting, the nutrient responsive pathway must exert its eﬀects
on mTOR downstream of TSC1/2.
An observation from earlier work in our lab and others, con-
cerning amino acid stimulation of mTOR signaling was, the
sensitivity of S6K1 and 4EBP1 phosphorylation to wortman-
nin. This phenomenon was attributed to a class I PI3K input
to mTOR independent of PKB or oﬀ-target eﬀects of wort-
mannin on mTOR. Likewise, Nobukuni et al. [42] show a lack
of PKB phosphorylation in response to amino acid stimula-
tion, even when a robust S6K1 phosphorylation is observed.
While the insulin stimulation here is sensitive to rapamycin,
it is also sensitive to concentrations of wortmannin well below
those necessary to inhibit mTOR. Using siRNA to Class I
PI3K we show that while insulin no longer results in stimula-
tion of S6K1 or PKB, amino acid stimulation readily induces
phosphorylation of S6K1. Therefore, amino acid stimulation
of mTOR is not transduced through Class I PI3K or PKB.
Due to its sensitivity to wortmannin we chose the Class III
PI3K hVPS34 as a candidate signaling intermediate between
amino acids and mTOR. Unlike Class I PI3K, which produces
the phosphatidylinositide triphosphate PI(3,4,5)P (PIP3), the
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a substrate to produce the monophosphate signaling molecule
PI(3)P. Using a monoclonal antibody engineered to speciﬁcally
recognize PI(3)P and confocal microscopy we showed a loss of
PI(3)P signal during amino acid deprivation followed by a
strong PI(3)P signal upon re-addition of amino acids to the cell
culture media. This experiment was carried out in Hela, WT
MEFs and TSC null MEFs indicating that the TSC1/2 com-
plex was not controlling the ﬂuctuation of PI(3)P in the cell.
To ensure that the Class III PI3K was the enzyme responsible
for the PI(3)P production, we used an in vitro PI3K assay to
measure hVPS34 activity before, during and after amino acid
deprivation and stimulation. Indeed, activity of hVPS34 was
determined by amino acid availability in the culture media in
each cell line tested.
Epitope-tagged S6K1 was expressed with increasing amounts
of hVPS34, and, while phosphorylation of S6K1 (i.e., mTOR
activity) was not resistant to amino acid deprivation, amino
acid stimulation resulted in hVPS34-dose dependent phosphor-
ylation of S6K1. Using expression of a hVPS34-dominant neg-
ative acting FYVE domain construct, which binds available
cellular PI(3)P, we can block the amino acid-induced phosphor-
ylation of co-expressed S6K1. The immunocytochemistry,
in vitro kinase assay and gain-of-function overexpression assays
detailed above make a very strong case for hVPS34 regulation
of amino acid-induced mTOR activity. The loss-of-function
siRNA experiments, however, are the vital experiments that
prove our hypothesis. RNAi of hVPS34 blocked completely
the phosphorylation of S6K1 in response to amino acid and
insulin stimulation while retaining Class I PI3K-induced phos-
phorylation of PKB after insulin treatment. Not only can we
block the activation ofmTORby amino acids by hVPS34RNAi
but RNAi of the hVPS34 adaptor hVPS15 (p150), a protein ki-
nase with unknown targets, also results in a block of mTOR
activity to S6K1 substrate. During the completion of this man-
uscript Byﬁeld et al. [43] published similar results to our own
describing a general nutrient regulation of hVPS34 activity.
Tassa et al. [90] previously reported an increase in hVPS34
activity associated with the amino acid starvation signal and
implicated the activity of hVPS34 with the BECN-1 tumor sup-
pressor in macroautophagy in C2C12 cells. While these results
appear to be at odds with ours they can be explained by Kihara
et al.’s [91] description of multiple hVPS34 complexes, where
some control autophagy and others are associated with endo-
cytic traﬃcking and sorting. Recently Zeng et al. [92] reported
that those hVPS34 complexes that contain BECN-1 are specif-
ically acting as modulators of autophagy, while hVPS34 com-
plexes without BECN-1 were important for cellular traﬃcking
events. Review papers on the subject of amino acid stimulation
of mTOR ﬁve years before Nobukuni et al. [42] theorized that
the wortmannin-sensitive stimulation of S6K1 could be due to
hVPS34 [93]. Thanks to advances in our biochemical cell-based
assays we were able to prove these theories correct.
The intimate relationship of amino acids, mTOR, hVPS34
and cellular traﬃcking is augmented by the research from Edin-
ger and Thompson [94] regarding endocytosis of nutrient trans-
porters during periods of growth factor withdrawal. Using an
IL-3 dependent cell line these researchers were able to show that
4F2hc/CD98, the heavy chain of the LAT1 and LAT2 amino
acid transporters, was localized to the lysosome during IL-3
withdrawal. This eﬀect could be reversed upon expression of
a constitutively active PKB construct and was reversed by rap-amycin treatment implicating mTOR. In a follow-up study an
exogenously expressed, activated allele of mTOR could also
rescue 4F2hc/CD98 lysosomal breakdown during IL-3 with-
drawal [95]. In fact cells expressing the activated mTOR were
resistant to growth factor withdrawal-induced apoptosis but re-
mained sensitive to nutrient withdrawal. Activity of the system
A amino acid transporter also appears to be under control of
leucine-mTOR signaling in a translation-dependent manner
[96,97]. Thus mTOR signaling can inﬂuence amino acid trans-
port at the transcriptional level (LAT1 light chain), the transla-
tional level (system A transport), and at the level of transporter
turnover (LAT1 heavy chain – 4F2hc/CD98).
Recent research has also focused on the role of Rheb in medi-
ating the amino acid signal to mTOR. Long et al. [14] described
domain speciﬁc interactions between Rheb and mTOR, Rheb
and raptor, and Rheb and mLST8. A follow-up article exam-
ines the Rheb–mTOR interaction and its dependency on extra-
cellular amino acids and/or leucine [98]. While the results
shown in both studies are clear, they employ immunoprecipita-
tion (IP) with exogenously expressed constructs to illustrate
interactions as opposed to IP of endogenous proteins. Whether
Rheb and mTOR/raptor/mLST8 interact at in vivo levels in an
amino acid-dependent manner remains to be seen. Roccio et al.
[99] show that while Rheb activity (as measured by percentage
of GTP-bound Rheb) is upregulated by insulin, this stimulation
is blocked by amino acid depletion. Amino acids alone, how-
ever, were insuﬃcient to modulate GTP loading on Rheb in a
wild-type setting. Nobukuni et al. [42] also demonstrates the
full activation of Rheb in a TSC2 null background regardless
of amino acid depletion even though S6K1 dephosphorylation
occurs. While exogenous Rheb can clearly regulate mTOR sig-
naling its precise function in nutrient activation of mTOR re-
mains unknown.
Regarding mTOR interactions, what is known however is
that the raptor–mTOR interaction is nutrient regulated [26].
In the initial description, raptor–mTOR binding is only de-
tected under speciﬁc mild lysing buﬀer conditions. During IP
of mTOR at its N-terminus the altered nature of the interac-
tion is displayed as a reduced amount of raptor seen in Wes-
tern blot post-IP upon stimulation with leucine. However, if
a reversible cross-linker is added before IP the amount of rap-
tor that co-IPs with mTOR during leucine deprivation and
stimulation remains the same. This indicates that a dynamic
interaction between mTOR and raptor occurs upon nutrient
stimulation where the actual amount of raptor bound remains
stable but the nature of the interaction (i.e., number of binding
sites) changes. More recently, Sarbassov and Sabatini [100] re-
ported that the raptor–mTOR interaction is a redox-sensitive
event where reducing reagents result in more raptor bound
to mTOR even in amino acid replete conditions. Although this
interaction is clearly dynamic it is currently considered an ob-
served phenomenon due to nutrient availability and not a
mechanism regulating mTOR activity.4. Live animal models
Several studies since the 1970s have illustrated the relation-
ship between supplementation of amino acids in diet with pro-
tein synthesis and restriction of dietary amino acids with
protein degradation [101–103]. Since the discovery of the nutri-
ent sensitive mTOR pathway several of the eﬀects of dietary
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sponse. Reiter et al. [104] observed a rapamycin-sensitive
hyperphosphorylation of 4EBP1 upon leucine administration
in rat liver after fasting. Similarly, phosphorylation of S6K1
and S6 was strong after leucine administration but was ablated
by addition of rapamycin. Reiter et al. also observed that the
increase in ribosomal proteins being actively translated on pol-
ysomes after leucine administration was rapamycin sensitive.
Similar results have been recorded in mammalian skeletal mus-
cle tissue [105] and adipose tissue [106]. Other researchers have
shown that S6K1 phosphorylation is enhanced 3–4-fold after
resistance exercise due to supplementation of leucine in human
subjects [107]. Other reports in elderly human subjects reveal a
dysregulation of S6K1 resulting in constitutively high phos-
phorylation before and after perfusion of insulin and amino
acids. This dysregulation is correlated with an impaired pro-
tein synthesis response in elderly compared with young sub-
jects [108]. VPS34 activity assays in mammalian live animal
models have not yet been performed to determine the eﬀect
of dietary amino acid intake on VPS34 function. The results
of aging on S6K1 signaling is especially intriguing considering
the lifespan extension eﬀects of nutrient restriction and/or
expression of dominant negative constructs of TOR and
S6K1 in Drosophila and Caenorhabditis elegans [109,110].
Research in Drosophila has revealed two distinct amino acid
sensors/transporters that are linked to TOR function. Goberd-
han et al. [111] identiﬁed a proton-assisted amino acid trans-
porters (PATH) which genetically interacts with TOR in an
amino acid-dependent way. PATH is especially important dur-
ing ﬂy development, controlling growth and speciﬁcally modu-
lating TOR signaling. Slimfast, another amino acid transporter,
was recently identiﬁed within the Drosophila fat body and ap-
pears to involve TSC/TOR signaling [112]. Downregulation of
slimfast results in a global growth defect and demonstrates a hu-
moral mechanism of growth control emanating from slimfast
activity in the fat body. The involvement of amino acid sensing
in mammalian development is also observed in blastocyst out-
growth, as embryonic implantation will not occur without
transport of exogenous amino acids [113]. These researchers
show that trophectoderm diﬀerentiation is dependent on the
amino acid transport that stimulates mTOR and subsequent
S6K1 phosphorylation. This data is recapitulated by data from
mice in our own lab [114] and others [115] where mTOR dele-
tion results in early embryonic lethality before implantation.
As stated earlier several amino acid transporters, especially
the system L transporters, are upregulated in diﬀerent forms
of cancer. In a recent report LAT1 expression is well correlated
with poor survival in glioblastoma and expression of LAT1 was
a good predictor of outcome independent of other variables
[116]. These researchers also describe a dose-dependent
in vitro and in vivo reduced growth response of rat glioma C6
cells treated with BCH. While one could extrapolate that in-
creased expression of obligatory leucine transporters would re-
sult in increased mTOR signaling, correlations between
increased system L transport activity and increased mTOR
activity have yet to be made in a cancer setting or otherwise.5. Conclusions
Activation of mTOR through stimulation of cellular signal-
ing pathways by growth factors is well described relative tonutrients. In yeast the nutrient sensitive retrograde response
has been linked to Torp function as has the regulation of ami-
no acid permeases in response to nutrient availability. In mam-
malian systems amino acids, especially leucine, modulate
mTOR phosphorylation of S6K1 and 4EBP1. No amino acid
or leucine-speciﬁc receptor has been identiﬁed that results in
a signaling cascade to activate mTOR. Evidence suggests,
however, that this receptor is independent of the one responsi-
ble for suppressing autophagy. Our lab has identiﬁed the Class
III PI3K hVPS34 as a regulator of mTOR activity in response
to nutrients. In fact, the activity of hVPS34 is itself regulated
by nutrient availability as illustrated by results from our lab
and others. Results from live animal models generally recapit-
ulate those found in cell culture and evidence from Drosophila
and yeast models implicates amino acid transporters as impor-
tant mediators of TOR signaling. The link between mTOR
activity and nutrient transporter turnover through endocytosis
as described by Edinger and Thompson [94,95], as well as the
control of amino acid transporter expression at the level of
transcription [83] and translation [96,97] through rapamycin
sensitive mechanisms, is indicative of the intimate relationship
between nutrient transporters and the mTOR pathway. Future
studies that examine the link between amino acid transport,
hVPS34 activity and mTOR activity will resolve the initial sig-
naling events that result in activation of mTOR targets and
provide insight into the opportunistic scavenging of nutrients
by malignant cells.
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